August 28, 2020 A proposed class action claims Fastly, Inc. failed to disclose to investors that its largest customer was the Chinese company behind the controversial TikTok app.
August 28, 2020 Blink faces a class action that claims investors were harmed financially after it was revealed the company misrepresented its electric car charging network.
August 26, 2020 A class action alleges Vaxart and Armistice Capital participated in a "pump and dump" scheme whereby they boosted stock prices on the back of multiple false COVID-19 vaccine proclamations.
August 20, 2020 Genius Brands faces a lawsuit in which an investor claims stockholders have been harmed financially by the company's misstatements and a resulting drop in stock price.
August 17, 2020 Eastman Kodak Co. and its CEO and CFO face a class action after a $765M federal loan to produce COVID-19 drug materials was paused over concerns of alleged insider trading.
July 31, 2020 An Intel investor claims a drop in stock price is linked to the company’s failure to disclose impending production delays for its 7-nanometer CPU technology.
July 10, 2020 Wirecard AG, former execs and auditor Ernst & Young face a securities class action in the wake of the global payment processor's collapse.
June 23, 2020 Chembio Diagnostics faces a class action centered on the FDA's revocation of an emergency use authorization for the company's COVID-19 antibody test.
June 16, 2020 A class action alleges Co-Diagnostics, Inc. caused investors to lose millions when the FDA contradicted the company’s “100% accuracy” claims for its COVID-19 tests.
June 9, 2020 An investor has filed a class action against Wells Fargo alleging the bank's handling of small business PPP loan applications harmed stock prices.
May 28, 2020 A class action claims Carnival Corporation and two top execs harmed investors by omitting or failing to disclose information on the company's handling of the COVID-19 outbreak.
March 3, 2020 A lawsuit claims EquiAlt and several co-conspirators have executed a "classic Ponzi scheme" that has scammed over 1,000 investors out of more than $170 million.